Enovis Corp (ENOV) Narxning foydaga nisbati

Enovis Corp (ENOV) korporativ emblemasi va logotipi

Muolajalar hajmining ortishi va aholining qarishi Enovis Corporation (ENOV) mijozlar bazasini kengaytirmoqda. GURU.Markets grafik ma'lumotlariga asoslangan joriy P/E baholashi, bunda ko'rsatkich -3.10 darajasida turibdi, investitsiya jozibadorligini tasdiqlaydi. Barqaror daromad shifokorlarning implantlarni tanlashdagi konservativligi bilan ta'minlanmoqda, tizim xizmatlarining yuqori narxi esa jarrohlarining kompaniyaning maxsus texnologik yechimlariga bog'lanib qolganligi bilan asoslanadi.

Enovis Inc. (ENOV) Narx-foyda koeffitsiyenti: 28.04.2023 - 17.11.2026 davri uchun

Enovis (ENOV) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning umumiy tahlili:Enovis Corp - ENOV
enovis.com original mahsuloti

P/E koeffitsiyenti bozor qiymatining sof foydaga nisbatini hisobga olgan holda, investitsiya qilingan mablag'larning qoplanish muddatini belgilaydi va bir dollar foydaning joriy qiymatini aks ettiradi. Enovis Corporation (ENOV) uchun ushbu hisob-kitob ortopedik implantlar patentlarining kengayish samaradorligini tasdiqlaydi; shuning uchun, P/E biznes qiymatini baholash tahlili adolatli kirish chegarasini aniqlash imkonini beradi va kapitalni kelajakdagi o'sish uchun haddan tashqari ko'p to'lov qilishdan himoya qiladi.

Raqobatdosh kompaniyalar tahlili

Narxning foydaga nisbati BSX|Narx-foyda koeffitsiyenti EW (Edwards Lifesciences Corporation)|Biznesning o‘zini qoplash muddati ResMed Inc.|P/E multiplikatori PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Kapitalizatsiyaning sof foydaga nisbati|CooperSurgical - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati ALGN|GMED: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TransMedics Group (TMDX)|ATEC (Alphatec) - P/E multiplikatori|Narx-foyda multiplikatori AORT (Artivion)|Narx-foyda koeffitsiyenti IART (Integra LifeSciences Holdings Corporation)|ESTA (Establishment Labs Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati iLet Bionic Pancreas BBNX|IRMD - Narx-foyda koeffitsiyenti|Embecta Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tandem Diabetes Care|AXGN: P/E multiplikatori|Narx-foyda multiplikatori SIBN|OFIX (Orthofix Corp) - P/E multiplikatori|Narx-foyda koeffitsiyenti Bioventus Corp (BVS)|P/E multiplikatori KIDS|Narx-foyda koeffitsiyenti Treace Medical Concepts TMCI|P/E multiplikatori SRTA (blade.com)|P/E multiplikatori Carlsmed, Inc. CARL|RXST - Narxning foydaga nisbati|CLPT: Narxning foydaga nisbati|STXS (Stereotaxis, Inc.) - Narx-foyda koeffitsiyenti|Neuronetics, Inc. - Kompaniya qiymatining sof foydaga nisbati|SGHT (Sight Sciences Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Orchestra BioMed Inc. OBIO|Narxning foydaga nisbati Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Jin Medical International Ltd. - Narx-foyda koeffitsiyenti|P/E multiplikatori Vivani VANI|Xtant Medical Holdings, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati NeuroOne NMTC|Modular Medical, Inc. (MODD) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Myomo, Inc|Narxning foydaga nisbati envoymedical.com|Narx-foyda koeffitsiyenti Vivos Therapeutics (VVOS)|P/E multiplikatori NVNO|SINT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical, Inc. TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati invobioscience.com IVF|BBLG: P/E multiplikatori|Axonics Modulation Technologies (AXNX) - P/E multiplikatori|BIOL (Biolase Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati dynatronics.com DYNT|P/E multiplikatori FNA|Narxning foydaga nisbati INVO (INVO Bioscience Inc.)